These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 221532)

  • 1. Inhibition of angiotensin converting enzyme activity in cultured endothelial cells by hypoxia.
    Stalcup SA; Lipset JS; Woan JM; Leuenberger P; Mellins RB
    J Clin Invest; 1979 May; 63(5):966-76. PubMed ID: 221532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of pathophysiologic state on the metabolism of vasoactive peptides by mammalian lung.
    Stalcup SA; Leuenberger P; Greenbaum LM; Mellins RB; Turino GM
    Bull Eur Physiopathol Respir; 1979; 15(5):1031-44. PubMed ID: 228783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of vasoactive peptides by human endothelial cells in culture. Angiotensin I converting enzyme (kininase II) and angiotensinase.
    Johnson AR; Erdös EG
    J Clin Invest; 1977 Apr; 59(4):684-95. PubMed ID: 191471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin I-converting enzyme localization on cultured fibroblasts by immunofluorescence.
    Weinberg KS; Douglas WH; MacNamee DR; Lanzillo JJ; Fanburg BL
    In Vitro; 1982 Apr; 18(4):400-6. PubMed ID: 6288549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kininase II (angiotensin converting enzyme) and endothelial cells in culture.
    Ryan US; Ryan JW; Chiu A
    Adv Exp Med Biol; 1976; 70(00):217-27. PubMed ID: 180764
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression of angiotensin-converting enzyme activity in cultured pulmonary artery endothelial cells.
    Del Vecchio PJ; Smith JR
    J Cell Physiol; 1981 Sep; 108(3):337-45. PubMed ID: 6270164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hypoxia on the conversion of angiotensin I to II in cultured porcine pulmonary endothelial cells.
    Szidon P; Oparil S; Osikowicz G; Booyse FM
    Biochem Pharmacol; 1983 Apr; 32(7):1201-5. PubMed ID: 6303352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of converting enzyme activity by acute hypoxia in dogs.
    Stalcup SA; Lipset JS; Legant PM; Leuenberger PJ; Mellins RB
    J Appl Physiol Respir Environ Exerc Physiol; 1979 Feb; 46(2):227-34. PubMed ID: 217854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of converting enzyme activity by hypoxia and its physiological effects.
    Stalcup SA; Lipset JS; Mellins RB
    Ciba Found Symp; 1980; 78():293-311. PubMed ID: 6258882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of angiotensin I-converting enzyme by endothelial cells in vitro.
    Noveral JP; Mueller SN; Levine EM
    J Cell Physiol; 1987 Apr; 131(1):1-5. PubMed ID: 3032989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial angiotensin-converting enzyme and neutral endopeptidase in isolated human umbilical vein: an effective bradykinin inactivation pathway.
    Nowak W; Errasti AE; Armesto AR; Santín Velazque NL; Rothlin RP
    Eur J Pharmacol; 2011 Sep; 667(1-3):271-7. PubMed ID: 21651905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary angiotensin-converting enzyme and its inhibition: a historical survey.
    Bakhle YS
    Ciba Found Symp; 1980; 78():275-92. PubMed ID: 6258881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction by glucocorticoids of angiotensin converting enzyme production from bovine endothelial cells in culture and rat lung in vivo.
    Mendelsohn FA; Lloyd CJ; Kachel C; Funder JW
    J Clin Invest; 1982 Sep; 70(3):684-92. PubMed ID: 6286730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of [3H]benzoyl-phenylalanyl-alanyl-proline by pulmonary angiotensin converting enzyme in vivo: effects of bradykinin, SQ 14225 or acute hypoxia.
    Catravas JD; Gillis CN
    J Pharmacol Exp Ther; 1981 May; 217(2):263-70. PubMed ID: 6262480
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin I converting enzyme (kininase II) in human endothelial cells in culture.
    Johnson AR; Erdos EG
    Adv Exp Med Biol; 1979; 120B():287-95. PubMed ID: 229705
    [No Abstract]   [Full Text] [Related]  

  • 16. Bradykinin degrading activity in cultured human endothelial cells.
    Graf K; Gräfe M; Auch-Schwelk W; Baumgarten CR; Bossaller C; Fleck E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S16-20. PubMed ID: 1282624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of angiotensin converting enzyme (kininase II). II. Immunocytochemistry and immunofluorescence.
    Ryan US; Ryan JW; Whitaker C; Chiu A
    Tissue Cell; 1976; 8(1):125-45. PubMed ID: 178068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung angiotensin converting enzyme activity in chronically hypoxic rats.
    Kay JM; Keane PM; Suyama KL; Gauthier D
    Thorax; 1985 Aug; 40(8):587-91. PubMed ID: 2994249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin converting enzyme and hypoxia.
    Milledge JS
    Bull Eur Physiopathol Respir; 1984; 20(6):481-5. PubMed ID: 6097325
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.